Guru Ownership Trend
Guru Analysis for Aura Biosciences, Inc. (AURA)
Aura Biosciences, Inc. (AURA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.93 M.
Top institutional holders include Renaissance Technologies (RenTech) and Ken Fisher.
Institutional sentiment is currently Bullish. This is evidenced by a $265,625.43 net inflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 232.9%. Conversely, Steven Cohen reduced exposure by 60.3%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Aura Biosciences, Inc. (AURA)
Major holders include Renaissance Technologies (RenTech) ($683,049), Ken Fisher ($558,668), Cliff Asness ($308,697). According to the latest reported data, 4 tracked investment managers collectively hold approximately 253,459 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $265,625.43, with 2 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited AURA. The total reported sell value was $509,002.69.
Yes, 1 managers opened new positions in AURA, and 1 increased their existing holdings. The total reported buy value was $774,628.12.